ADZYNMA

Medicinal product

(Invented) name

ADZYNMA

Active substance (s)

Žmogaus rekombinantinis "A dezintegrino ir metaloproteinazės su trombospondino 13 motyvais" (rADAMTS13) preparatas

Strength

500 TV

Pharmaceutical form

milteliai ir tirpiklis injekciniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

ATC code (s)

B01AD13, apadamtase alfa and cinaxadamtase alfa

Marketing authorisation holder

Takeda Manufacturing Austria AG, Austrija

Date of authorisation

2024-08-01

Date of renewal

Documents

Stage

Registruotas

Controlled?

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Flakone yra:	1 vnt.
Žmogaus rekombinantinis "A dezintegrino ir metaloproteinazės su trombospondino 13 motyvais" (rADAMTS13) preparatas	500 TV

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
114695	100802	1100802	flakonas	milteliai, tirpiklio flakonas (5 ml), „BAXJECT II Hi-Flow“ priemonė, švirkštas (10 ml), infuzijos rinkinys (25 dydžio), 2 alkoholiu sudrėkinti tamponai N1		Receptinis	EU/1/24/1837/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2024-08-01	Registruotas